{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:49:46Z","timestamp":1778939386109,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004172","name":"Mersin University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004172","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>We aimed to compare the efficacy of three different antiseptic methods to determine the most effective prophylactic approach to prevent infectious complications after transrectal ultrasound-guided prostate biopsy (TRUS-PB). The methods evaluated were transrectal povidone-iodine injection (TRPI), biopsy needle disinfection with chlorhexidine, and biopsy needle disinfection with formalin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Between January 2018 and January 2023, 904 patients who underwent TRUS-PB were retrospectively analyzed. All patients had prophylactic antibiotic use and negative urine\/rectal culture results. Patients were divided into three groups according to the antiseptic protocol: Group 1 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009245) received only TRPI injection into the rectum before biopsy, Group 2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009295) received only chlorhexidine needle disinfection before biopsy, and Group 3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009364) received only formalin needle disinfection before biopsy. The biopsy needles used in our clinic are not single-use and are used on other patients after sterilization. The primary endpoint was the incidence of infectious complications within 30 days post-procedure. Continuous variables were analyzed using the Mann-Whitney U test, while categorical variables were analyzed using the Chi-square test, and post-hoc analysis was applied for pairwise comparisons between groups. Univariate and multivariate logistic regression analysis was performed to evaluate factors associated with postoperative infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall infection rate was 20.4%. Infection rates were 4.5% in the TRPI group, 16.6% in the chlorhexidine group, and 34.1% in the formalin group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The TRPI group showed significantly lower rates of all infectious complications compared to other groups. Disinfection of biopsy needles with chlorhexidine was found to be significantly more effective in preventing infectious complications compared to disinfection with formalin (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TRPI injection before TRUS-PB appears to be more effective in preventing post-biopsy infectious complications compared to needle disinfection with chlorhexidine or formalin. This method may be considered as a preferred antiseptic approach for TRUS-PB procedures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-025-05498-4","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T04:27:02Z","timestamp":1738902422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevention of infectious complications after transrectal ultrasound-guided prostate biopsy: comparison of povidone-iodine, chlorhexidine, and formalin disinfection"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-4920","authenticated-orcid":false,"given":"Mert","family":"Ba\u015farano\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6325-1534","authenticated-orcid":false,"given":"Ali","family":"Nebio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8624-0149","authenticated-orcid":false,"given":"Murat","family":"Bozlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1902-4478","authenticated-orcid":false,"given":"Ali","family":"G\u00f6k\u00e7e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7669-414X","authenticated-orcid":false,"given":"Erdem","family":"Akbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"5498_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/CAAC.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/CAAC.21660","journal-title":"CA Cancer J Clin"},{"key":"5498_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJM198710083171501","volume":"317","author":"TA Stamey","year":"1987","unstructured":"Stamey TA, Yang N, Hay AR et al (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909\u2013916. https:\/\/doi.org\/10.1056\/NEJM198710083171501","journal-title":"N Engl J Med"},{"key":"5498_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.eururo.2020.12.010","volume":"79","author":"H Van Poppel","year":"2021","unstructured":"Van Poppel H et al (2021) Early detection of prostate Cancer in 2020 and Beyond: facts and recommendations for the European Union and the European Commission. Eur Urol 79:327. https:\/\/pubmed.ncbi.nlm.nih.gov\/33384200","journal-title":"Eur Urol"},{"key":"5498_CR4","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/J.EJCA.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374\u20131403. https:\/\/doi.org\/10.1016\/J.EJCA.2012.12.027","journal-title":"Eur J Cancer"},{"key":"5498_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/J.EURURO.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876\u2013892. https:\/\/doi.org\/10.1016\/J.EURURO.2013.05.049","journal-title":"Eur Urol"},{"key":"5498_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/J.EURURO.2016.08.004","volume":"71","author":"M Borghesi","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R et al (2017) Complications after systematic, Random, and image-guided prostate biopsy. Eur Urol 71:353\u2013365. https:\/\/doi.org\/10.1016\/J.EURURO.2016.08.004","journal-title":"Eur Urol"},{"key":"5498_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/J.EURURO.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618\u2013629. https:\/\/doi.org\/10.1016\/J.EURURO.2016.08.003","journal-title":"Eur Urol"},{"key":"5498_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/J.EURURO.2013.09.046","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124\u2013137. https:\/\/doi.org\/10.1016\/J.EURURO.2013.09.046","journal-title":"Eur Urol"},{"key":"5498_CR9","doi-asserted-by":"publisher","unstructured":"Averch T, Tessier C, Clemens JQ et al (2015) AUA Quality Improvement Summit 2014: Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy. Urol Pract 2:172\u2013180. https:\/\/doi.org\/10.1016\/J.URPR.2014.10.011","DOI":"10.1016\/J.URPR.2014.10.011"},{"key":"5498_CR10","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/J.EURURO.2008.03.033","volume":"54","author":"AMJ Bootsma","year":"2008","unstructured":"Bootsma AMJ, Laguna Pes MP, Geerlings SE, Goossens A (2008) Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 54:1270\u20131286. https:\/\/doi.org\/10.1016\/J.EURURO.2008.03.033","journal-title":"Eur Urol"},{"key":"5498_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/J.IJANTIMICAG.2011.09.008","volume":"38","author":"M Grabe","year":"2011","unstructured":"Grabe M (2011) Antibiotic prophylaxis in urological surgery, a European viewpoint. Int J Antimicrob Agents 38:58\u201363. https:\/\/doi.org\/10.1016\/J.IJANTIMICAG.2011.09.008","journal-title":"Int J Antimicrob Agents"},{"key":"5498_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/J.JURO.2009.11.043","volume":"183","author":"RK Nam","year":"2010","unstructured":"Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963\u2013969. https:\/\/doi.org\/10.1016\/J.JURO.2009.11.043","journal-title":"J Urol"},{"key":"5498_CR13","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/J.JURO.2010.11.088","volume":"185","author":"MA Liss","year":"2011","unstructured":"Liss MA, Chang A, Santos R et al (2011) Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 185:1283\u20131288. https:\/\/doi.org\/10.1016\/J.JURO.2010.11.088","journal-title":"J Urol"},{"key":"5498_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/J.JURO.2015.03.110","volume":"194","author":"MA Liss","year":"2015","unstructured":"Liss MA, Kim W, Moskowitz D, Szabo RJ (2015) Comparative effectiveness of targeted vs empirical antibiotic prophylaxis to prevent Sepsis from Transrectal Prostate Biopsy: a retrospective analysis. J Urol 194:397\u2013402. https:\/\/doi.org\/10.1016\/J.JURO.2015.03.110","journal-title":"J Urol"},{"key":"5498_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/AJA.2011.130","volume":"14","author":"PF Shen","year":"2012","unstructured":"Shen PF, Zhu YC, Wei WR et al (2012) The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl 14:310\u2013315. https:\/\/doi.org\/10.1038\/AJA.2011.130","journal-title":"Asian J Androl"},{"key":"5498_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/BJU.12536","volume":"114","author":"JP Grummet","year":"2014","unstructured":"Grummet JP, Weerakoon M, Huang S et al (2014) Sepsis and superbugs: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 114:384\u2013388. https:\/\/doi.org\/10.1111\/BJU.12536","journal-title":"BJU Int"},{"key":"5498_CR17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/ARCHSURG.141.12.1168","volume":"141","author":"A Valverde","year":"2006","unstructured":"Valverde A, Msika S, Kianmanesh R et al (2006) Povidone-iodine vs sodium hypochlorite enema for mechanical preparation before elective open colonic or rectal resection with primary anastomosis: a multicenter randomized controlled trial. Arch Surg 141:1168\u20131174. https:\/\/doi.org\/10.1001\/ARCHSURG.141.12.1168","journal-title":"Arch Surg"},{"key":"5498_CR18","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.3892\/OL.2019.10212","volume":"17","author":"X Ye","year":"2019","unstructured":"Ye X, Zhao L, Kang J (2019) Expression and significance of PTEN and Claudin-3 in prostate cancer. Oncol Lett 17:5628\u20135634. https:\/\/doi.org\/10.3892\/OL.2019.10212","journal-title":"Oncol Lett"},{"key":"5498_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/S41391-017-0004-Y","volume":"21","author":"GT Werneburg","year":"2018","unstructured":"Werneburg GT, Kongnyuy M, Halpern DM et al (2018) Patient-reported quality of life progression in men with prostate cancer following primary cryotherapy, cyberknife, or active holistic surveillance. Prostate Cancer Prostatic Dis 21:355\u2013363. https:\/\/doi.org\/10.1038\/S41391-017-0004-Y","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5498_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/bju.15675","volume":"129","author":"W Lam","year":"2022","unstructured":"Lam W, Wong A, Chun S, Wong T et al (2022) Prostate cancer detection, tolerability and safety of transperineal prostate biopsy under local-anaesthesia vs standard transrectal biopsy in biopsy-naive men: a pragmatic, parallel group, randomized controlled study. BJU Int 129:9. https:\/\/doi.org\/10.1111\/bju.15675","journal-title":"BJU Int"},{"key":"5498_CR21","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/s0022-5347(05)65112-9","volume":"167","author":"JM Carey","year":"2002","unstructured":"Carey JM, Korman HJ, Terris MK (2002) Re: transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 167:2145\u20132146. https:\/\/doi.org\/10.1016\/s0022-5347(05)65112-9","journal-title":"J Urol"},{"key":"5498_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00345-016-1867-6","volume":"35","author":"T Cai","year":"2017","unstructured":"Cai T, Gallelli L, Cocci A et al (2017) Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World J Urol 35:221\u2013228. https:\/\/doi.org\/10.1007\/s00345-016-1867-6","journal-title":"World J Urol"},{"key":"5498_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/sur.2013.138","volume":"15","author":"DS Park","year":"2014","unstructured":"Park DS, Hwang JH, Choi DK, Gong IH, Hong YK, Park S et al (2014) Control of infective complications of transrectal prostate biopsy. Surg Infect (Larchmt) 15:431\u2013436. https:\/\/doi.org\/10.1089\/sur.2013.138","journal-title":"Surg Infect (Larchmt)"},{"key":"5498_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5812\/IRANJRADIOL.7561","volume":"9","author":"M Ghafoori","year":"2012","unstructured":"Ghafoori M, Shakiba M, Seifmanesh H, Hoseini K (2012) Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial. Iran J Radiol 9:63\u201366. https:\/\/doi.org\/10.5812\/IRANJRADIOL.7561","journal-title":"Iran J Radiol"},{"key":"5498_CR25","doi-asserted-by":"publisher","unstructured":"Bostanc\u0131 C (2024) Nonantibiotic strategies to decrease the postbiopsy hospitalization rates because of infectious complications after transrectal prostate biopsy. https:\/\/doi.org\/10.1002\/pros.24677. Prostate","DOI":"10.1002\/pros.24677"},{"key":"5498_CR26","doi-asserted-by":"publisher","unstructured":"Ryu H, Song SH, Lee SE et al (2019) A prospective randomized trial of povidone-iodine suppository before transrectal ultrasonography-guided prostate biopsy. Medicine 98. https:\/\/doi.org\/10.1097\/MD.0000000000014854","DOI":"10.1097\/MD.0000000000014854"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05498-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05498-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05498-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:02:12Z","timestamp":1767996132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05498-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5498"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05498-4","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Local Ethics Committee of Mersin University Faculty of Medicine with decision number 2023\/695 dated October 18, 2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No competing of interest was declared by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}